Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06160986 · ClinicalTrials.gov registry record · NA

Horizons Chronic Graft-Versus-Host-Disease Study

A NA study of Quality of Life and Graft Vs Host Disease, sponsored by University of Miami.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06160986: Active NA study of Quality of Life and Graft Vs Host Disease, sponsored by University of Miami.

NCT06160986 is a NA study of Quality of Life and Graft Vs Host Disease that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 20 participants, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06160986, a NA study of Quality of Life and Graft Vs Host Disease, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

Primary Outcome

Participant enrollment will be demonstrated if ≥50% eligible participants enroll

Interventions

  • BEHAVIORAL Horizons Group Intervention

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-12-27
Est. Completion 2025-12-31
Phase NA
University of Miami

721 total trials

What the registry record for NCT06160986 still lists

NCT06160986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Horizons Group Intervention is the first listed.

NCT06160986 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06160986 about?

NCT06160986 is a clinical study titled "Horizons Chronic Graft-Versus-Host-Disease Study". This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

What is the current status of trial NCT06160986?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-12-27. Estimated completion is 2025-12-31.

What conditions does trial NCT06160986 study?

This clinical trial studies the following conditions: Quality of Life, Graft Vs Host Disease, Coping Skills, Stem Cell Transplant Complications.

What interventions are being tested in trial NCT06160986?

The interventions under investigation include: Horizons Group Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06160986?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06160986 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06160986's enrollment target sits among peer trials

20 98th of 107 higher than 8 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06160986, the US trial registry maintained by the National Library of Medicine. NCT06160986 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.